950220.KQ
NeoImmuneTech, Inc.
KOE · Healthcare · Biotechnology · US
KRW 1,632.00
−2.68%Year over year
Reported trailing growth
- Revenue
- -43.8%
- EBITDA
- —
- EBIT
- +32.4%
- EPS
- —
- Free cash flow
- +44.1%
- Operating cash flow
- +42.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -44.4%
- EBITDA
- —
- EBIT
- +32.4%
- Net income
- +21.3%
- EPS
- +90.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025